Endoscopic retrograde cholangiopancreatography (ERCP) in children with pancreatic diseases
Journal Title: Postępy Nauk Medycznych - Year 2014, Vol 27, Issue 3
Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) is nowadays a valuable method for detailed diagnostic evaluation and minimally invasive therapy for biliary and pancreatic diseases in pediatric population. The technique of ERCP is no more difficult in children than in adults, and except infants, there is no need for use a special pediatric endoscope. In children ERCP is usually performed with the patient under general anesthesia. Routine antibiotic prophylaxis is controversial, because there is no pediatric data regarding this problem. Pediatric indications for ERCP are similar to those for adults, though with a much lower incidence of malignant diseases. Among children with pancreatic diseases a common indications are: acute or recurrent acute pancreatitis, chronic pancreatitis, abdominal pain suspected to be of pancreaticobiliary origin, suspicion of pancreatic ductal anomaly, pancreatic trauma, differential diagnosis of focal pancreatic lesions and preoperative evaluation. Therapeutic ERCP constitutes 30-78% of all ERCPs and has a significant impact on the management of patients with pancreatic diseases, offering an alternative to surgical treatment in some cases. Pediatric studies demonstrates that ERCP has a high degree of technical success and a low rate of complications when performed by experienced endoscopists. MRCP nowadays has become the first-line diagnostic tool for biliopancreatic diseases and in the future ERCP may play a role mainly as a therapeutic intervention.
Authors and Affiliations
Elwira Kołodziejczyk, Karolina Wejnarska, Jarosław Kierkuś, Grzegorz Oracz
Keywords
Related Articles
- EP ID EP54937
- DOI -
- Views 172
- Downloads 0
Breast cancer – where are we standing in 2011?
Breast cancer is one of the major health and social problems in women. Due to the wide application of screening programs and to improvements in treatment, breast cancer mortality in some countries has decreased by more t...
Chromogranin A (CgA): structure, biological function, pre-analytical, analytical, and clinical aspects of its measurement in blood
Chromogranin A (CgA) is a main nonspecific neuroendocrine tumour (NET) marker. Currently few commercial assays are available: RIA, IRMA, ELISA, CLIA, TRACE. There are many factors: in vivo, in vitro and coexisting diseas...
Introduction of maternal and foetal morphological parameters of blood for calculation the postpartum anti-RhD immunoglobulin doses
<b>Introduction.</b> Doses of anti-RhD Ig for immunoprophylaxis of haemolytic disease of newborn (HDN) are established with reference to the volume of RhD positive foetal red blood cells in th...
Reliability of the results of drug susceptibility testing Mycobacterium tuberculosis as an important factor of supervised treatment of tuberculosis
Introduction. The discovery and introduction antituberculous drugs to the therapy in the second half of XX century, became a turning point in the history of tuberculosis. Unfortunately, this has resulted in closely assoc...
Stany przednowotworowe sromu – przegląd piśmiennictwa i doświadczenia własne
Wstęp. Stany przednowotworowe sromu podobnie jak zmiany przednowotworowe szyjki macicy początkowo klasyfikowano jako VIN 1, VIN 2 i VIN 3. Obecnie na podstawie zmian histopatologicznych przyjęto podział na uVIN i dVIN. O...